NJBIZ

Cellares raises $257M to scale automated cell therapy

Cellares has raised a $257 million Series D financing, bringing its total funding to $612 million. The latest comes as the cell therapy manufacturing company accelerates plans to industrialize ...
GEN

Producer Cell Lines: Large-Scale Gene Therapy Hitmakers

Gene therapies offer incredible promise for treating diseases with a genetic component. Several gene therapies are already available, and adeno-associated virus (AAV) has become a popular choice for ...
GEN

Cellares and Technology Provider Team Plan to Expand Cell Q’s Capabilities for Commercial Scale Cell Therapy QC

Officials at Cellares say the Integrated Development and Manufacturing Organization (IDMO) entered multiple strategic technology partnerships to advance the Cell Q™, a fully automated quality control ...
Business Wire

Scale Biosciences Launches Five Single Cell Profiling Products, Unlocking Single Cell RNA Studies at Any Scale

SAN DIEGO--(BUSINESS WIRE)--Scale Biosciences (Scale Bio™), a leader in innovative and scalable single cell analysis solutions, today announced the availability of its QuantumScale Single Cell RNA ...
Hosted on MSN

Single-cell breakthrough decodes transcriptome, epigenome & 3D genome at once

A team led by Professor Inkyung Jung from the Department of Biological Sciences at KAIST, working with Professor Yarui Diao’s group, has published a new single-cell method called scHiCAR that ...